• about axogen
    • management team
    • board of directors
    • careers
    • partners
    • grants, donations, and sponsorships
    • code of ethics and conduct
    • patents
  • investors
  • news
  • contact
    • find a rep
    • international distributors
    • find referring surgeon
  • healthcare professionals
  • patients
Investors
  • Overview
  • News / Events
    • Overview
    • Press Releases
    • Axogen In the News
    • IR Calendar
    • Clinical Conferences
    • Presentations
    • Email Alerts
  • Financial Info
    • Overview
    • Balance Sheet
    • Income Statement
    • Cash Flow
    • Financial Results
  • Stock Data
    • Current Quote
    • Charts
    • Historical Data
    • Analyst Coverage
  • SEC Filings
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
    • Contact the Board
  • Additional Info
    • Contacts
    • FAQ
  • Investor Tools
    • Email Alerts
    • Tear Sheet
    • Contacts
    • RSS News Feed

Press Releases

AxoGen, Inc. Announces Enrollment of First Subject in Multicenter Comparative Study for Avance® Nerve Graft

Jun 23, 2015

AxoGen, Inc. to Present at the JMP Securities Life Sciences Conference

Jun 22, 2015

AxoGen, Inc. Chief Marketing Officer Named CEO of Privately-held Life Sciences Company

Jun 19, 2015

SPECIAL EVENT: “Geraldo Rivera Show” to Feature AxoGen, Inc. CEO Karen Zaderej to Discuss Role of Nerve Repair in Preserving Erectile Function After Prostatectomy – Final in a Series of Three Interviews

Jun 18, 2015

SPECIAL EVENT: “Geraldo Rivera Show” to Feature AxoGen, Inc. CEO Karen Zaderej Discussing Pain Caused by Nerve Injuries – Second in a Series of Three Interviews

Jun 17, 2015

SPECIAL EVENT: “Geraldo Rivera Show” to Feature AxoGen, Inc. CEO Karen Zaderej on Helping Our Injured Military Members – First in a Series of Three Interviews

Jun 16, 2015

AxoGen, Inc. To Host First International Surgeon Training Course and Announces Presentation of New Clinical Data at European Hand Meeting

Jun 15, 2015

AxoGen, Inc. Announces Completion of a Pilot Clinical Study Assessing Cavernous Nerve Reconstruction with Avance® Nerve Graft Following Radical Prostatectomy

Jun 9, 2015

AxoGen, Inc. Reports 58% Year-Over-Year Revenue Growth for the 2015 First Quarter

May 5, 2015

AxoGen, Inc. Announces Clearance from FDA to Proceed with New Multicenter Comparative Study for Avance® Nerve Graft

May 4, 2015
RSS
    • 1...
    • 22
    • 23
    • 24
    • 25
    • 26
    • 27
    • 28
    • 29
    • 30
    • 31
    • ...35
    Next

    13631 Progress Blvd, Suite 400
    Alachua, FL 32615

    • contact
    • careers
    • Privacy Policy
    • Terms and Conditions
    • Website Terms of Use
    • Legal Notices
    • Instagram Logo
    • Twitter Logo
    • Linkedin Logo
    • Facebook Logo

    © 2025 Axogen Corporation. The stylized "a" logo and Avance Nerve Graft are registered trademarks of Axogen Corporation.

    Top

    You are now leaving axogeninc.com

    Axogen is not responsible for content or policies on linked sites.